Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Vaccine|June 27, 2009
Preparation of bacterial polysaccharide-protein conjugates: analytical and manufacturing challengesCarl E FraschExpert Opinion on Biological Therapy|March 11, 2005
Recent developments in Neisseria meningitidis group A conjugate vaccinesCarl E FraschVaccine|May 26, 2009
Bactericidal antibody is the immunologic surrogate of protection against meningococcal diseaseCarl E Frasch, Ray Borrow, John DonnellyFEMS Immunology and Medical Microbiology|November 9, 2002
Immunologic and genetic characterization of lipooligosaccharide variants in a Neisseria meningitidis serogroup C strainPeixuan Zhu, Chao-Ming Tsai, Carl E FraschHuman Vaccines & Immunotherapeutics|April 13, 2012
Development of a group A meningococcal conjugate vaccine, MenAfriVac(TM)Carl E Frasch, Marie-Pierre Preziosi, F Marc LaForceCritical Reviews in Microbiology|November 26, 2003
Protective immunity of pneumococcal glycoconjugatesChi-Jen Lee, Lucia H Lee, Carl E FraschCritical Reviews in Microbiology|May 11, 2002
Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control testsLucia H Lee, Chi-Jen Lee, Carl E FraschClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 11, 2015
Technical Development of a New Meningococcal Conjugate VaccineCarl E Frasch, Subhash V Kapre, Che-Hung Lee, et al.Infection and Immunity|June 18, 2002
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responsesDavid S Berry, Freyja Lynn, Che-Hung Lee, et al.Clinical and Vaccine Immunology : CVI|November 6, 2009
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccinesJan T Poolman, Carl E Frasch, Helena Käyhty, et al.Pageof 3